|
|
This Web Site
This web site, along with regular emails, is the main means of regular
communication within BIRAs. Every effort is made to keep these pages as
current and as up-to-date as possible.
Please note, some of the contents are restricted to members only!
Contributions (see below for examples) to this site are welcome.
If you wish to contribute anything please contact: the
Web Site Editor
(neville.punchard@inflammation.ndo.co.uk).
This Web Site will eventually contain the following:
- A Diary section, giving details of forthcoming BIRAs meetings, with
pre-registration forms, and details of the meetings of other societies
and organisations that are pertinent to inflammation science. Where possible,
links to appropriate sites or contact details will be given. Organizers
of meetings of interest to inflammation researchers are invited to forward
details to the Web Site Editor.
- Information about BIRAs, such as minutes of committee meetings, business
matters, financial details, etc. (Note: these will be restricted to
members only).
- Details of previous BIRAs meeting and Meeting Reports for BIRAs meetings
(and for some other meetings where available).
- "Viewpoint" articles: Viewpoints are intended to be a forum
for brief articles proposing novel approaches to drug discovery,
summarising recent advances or critically reviewing areas of inflammation
research, and similar items. Controversial and iconoclastic articles are
especially welcome, as is correspondence or articles responding to the
views put forward in the Newsletter or during meetings of the Association.
Where an area of inflammation science is evidently controversial or in
need of clarification, this can help to identify the value of a one-day
BIRAs meeting on the topic.
All members of the Association
are invited to submit articles for Viewpoint.In order to give a
forum for novel thoughts and ideas, there is no refereeing of such contributions.
The format of Viewpoint articles is largely left to the author(s) to decide:
references can be included if appropriate, as can figures and graphs. The
overall length should aim to be up to around 4 pages of A4 (single-spaced).
- "Sites of inflammation" articles: This occasional series aims to
summarise the research activities underway in the research institutes in
the UK. For obvious reasons, such articles are perhaps unlikely to be contributed
by members working in the pharmaceutical industry. However, they
can be useful ways of stimulating new collaborations or dialogues between
groups with common interests.
All members of the Association are invited to submit articles for this
section: the format is as flexible as that described above for Viewpoint.
- Book Reviews: Occasional reviews of books within the very broad
area of inflammation research will be published in the Newsletter.
A copy of the review may also be published in Inflammation Research. BIRAs
already has agreements with a number of publishers, and hopes to extend
this system further. It would be helpful if members of the Association
who are willing to contribute reviews to the Newsletter in particular areas
of inflammation science would send details to the Web Site Editor. Volumes
for review would only be sent after a confirmatory telephone call checking
your willingness and availability to complete a review within a reasonable
time span. In general, if your review is published in the Newsletter,
you are free to keep the book. Copies of the review are also forwarded
to the publishers for their records.
- Job Vacancies.
- Links to other inflammation societies or oganisations, especially the Inflammation
Research Association (IRA) in the USA, the European Inflammation Society(EIS)
and the IAIS. Other links to potentailly useful site will also be included
where appropriate.
Members are encouraged to submit ideas for other features for this
web site. It is intended to make this site as useful as possible to members.
Any sugestion, ofers or comments on the web site should be addressed to
the Editor. All all articles, documents, etc. for
submission should be sent as attachments by email or by post. If sending
by post, the author should include both a hard (paper) copy
and a copy on 3.5" disk/RCD,(as either Microsoft Word (*.doc) or rich textformat
(*.rtf) documents.
|